Long-Term Efficacy and Safety Extension Study of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)

Written by ClinicalTrials.gov

Category: Bone diseases

Published: 08 August 2011

Conditions: Mucopolysaccharidosis IV A; Morquio A Syndrome; MPS IVA
Intervention: Drug: BMN 110
Sponsor: BioMarin Pharmaceutical
Enrolling by invitation - verified August 2011

Details: Last Updated: 08 August 2011

Find, Use, Share, Expand Orthopaedic Information

Improving orthopaedic care, education and research using Internet technologies